Showing 1 to 1 of 1 results
global.chinadaily.com.cn
🌐 75% Global Worthiness


Astellas to Launch Innovative Cancer Treatments in China Amidst Growing Market
Astellas, a multinational pharmaceutical company, is bringing two innovative cancer treatments to China, capitalizing on the country's massive consumer base, strengthened IP protection, and improved innovation climate; China's elderly population exceeded 20% in 2022.
Astellas to Launch Innovative Cancer Treatments in China Amidst Growing Market
Astellas, a multinational pharmaceutical company, is bringing two innovative cancer treatments to China, capitalizing on the country's massive consumer base, strengthened IP protection, and improved innovation climate; China's elderly population exceeded 20% in 2022.
Progress
36% Bias Score
Showing 1 to 1 of 1 results